Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris

This publication has 21 references indexed in Scilit:

• Trends in cardiovascular risk factors in Australia: Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980‐1989
  The Medical Journal of Australia, 1994
• Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension
  The American Journal of Cardiology, 1993
• Lowering cholesterol: effects on trauma death, cancer death and total mortality
  Australian and New Zealand Journal of Medicine, 1992
• Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
  BMJ, 1992
• Should there be a moratorium on the use of cholesterol lowering drugs?
  BMJ, 1992
• The Value of Lowering Cholesterol after Myocardial Infarction
  New England Journal of Medicine, 1990
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolemia
  The Medical Journal of Australia, 1990
• Sample Sizes for Comparing Two Independent Proportions Using the Continuity-Corrected Arc Sine Transformation
  Journal of the Royal Statistical Society: Series D (The Statistician), 1986
• Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register.
  Circulation, 1983